Following on from its success of delivering award winning own brand products, SPAR UK is set to release its latest offering into the medicine market.

The total medicine market is worth £2.5bn and is growing at a rate of 3% annually*. With rising prescription costs and some prescription medicines converting to over the counter, the expectation is that this growth will continue.

SPAR UK already has a successful own label medicine range, consisting of four Paracetamol and Ibuprofen lines, and this will increase with the addition of three new products:

• SPAR Cold Relief Capsules
• SPAR Diarrhoea Relief Capsules
• SPAR Hayfever & Allergy Relief Tablets

Commenting on the new releases, Cath McIlwham, Head of Brand at SPAR UK, said: “The medicine market is growing annually and our customers want more product choice offering better value for money. At SPAR, we are focused on meeting the needs of our shoppers and the three new own label medicines are yet another example of this.”

The medicines will be phased into SPAR stores between April and July 2017.

*SOURCE: Nielsen March 2016